
News|Articles|December 16, 2025
Two-Step Monoclonal Antibody Purification Using a Multi-Column Continuous Chromatography Platform
Author(s)Tosoh Bioscience
Each additional step in monoclonal antibody (mAb) downstream bioprocessing increases operating expenses and reduces the recovery of precious product. This Application Note, demonstrates how Multi-Column Chromatography (MCC), an integral part of continuous biomanufacturing, reduces operating time, buffer consumption, and resin usage, thereby decreasing operating expenses.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
China Approves First Monthly Biologic for COPD
2
CDC Revises Childhood Immunization Schedule, Shifting Demand Dynamics
3
Ultragenyx Phase III Data Reveal Limits of Bone Density Endpoints in Rare Bone Disease
4
FUJIFILM Irvine Scientific Rebrands as FUJIFILM Biosciences
5